PREVALENCE OF MULTIPLE SCLEROSIS

Information

  • Research Project
  • 3404893
  • ApplicationId
    3404893
  • Core Project Number
    R01NS022465
  • Full Project Number
    1R01NS022465-01A2
  • Serial Number
    22465
  • FOA Number
  • Sub Project Id
  • Project Start Date
    5/1/1987 - 37 years ago
  • Project End Date
    4/30/1989 - 35 years ago
  • Program Officer Name
  • Budget Start Date
    5/1/1987 - 37 years ago
  • Budget End Date
    4/30/1988 - 36 years ago
  • Fiscal Year
    1987
  • Support Year
    1
  • Suffix
    A2
  • Award Notice Date
    4/27/1987 - 37 years ago
Organizations

PREVALENCE OF MULTIPLE SCLEROSIS

To ascertain the prevalence of multiple sclerosis (MS) in hot coastal areas of Greek-speaking Cyprus and compare it with the prevalence in the mountain areas where the temperature is below zero for 4/5 months of the year. This will establish whether climatic temperature is a factor in the aetiology of MS and whether there is a high MS prevalence in sub-tropical Cyprus and not a low prevalence as was previously thought. A high Ms prevalence in Cyprus will show that there is a sudden fall in prevalence between southern Europe - Sicily and Cyprus - and Malta where the prevalence is low and so increase understanding of the surprising geographic differences in MS prevalence. The first year of the present study in Paphos District and in the mountains has shown that the experimental design of the study will provide the information that is sought. Because of the success of the study it is proposed that it should be continued for a further three years so that a second coastal area can be included and that it should be extended to include other neurological and neuromuscular diseases that may occur, and perhaps be unusually uncommon, in the areas studied and elsewhere in Cyprus, such as various forms of hereditary ataxia. The high frequency of Friedreich's Ataxia which was found during the first year of study in the villages of Kathikas/Arodhes has already provided an opportunity to locate the defective gene. The diagnosis of MS will be confirmed, when necessary, by magnetic resonance imaging (MRI) at the Hadassah Hospital, Jerusalem.

IC Name
NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
  • Activity
    R01
  • Administering IC
    NS
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    853
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    EDC
  • Study Section Name
    Epidemiology and Disease Control Subcommittee 3
  • Organization Name
    HEALTH RESEARCH BOARD
  • Organization Department
  • Organization DUNS
  • Organization City
    DUBLIN
  • Organization State
  • Organization Country
    IRELAND
  • Organization Zip Code
  • Organization District
    IRELAND